<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24339" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Cell Liquefactive Necrosis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Adigun</surname>
            <given-names>Rotimi</given-names>
          </name>
          <aff>Touro University College of Osteopathic Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Basit</surname>
            <given-names>Hajira</given-names>
          </name>
          <aff>Brookdale University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Murray</surname>
            <given-names>John</given-names>
          </name>
          <aff>University of Florida COM - Jacksonville</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rotimi Adigun declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hajira Basit declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>John Murray declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>7</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24339.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>
<bold>Cell Necrosis</bold>
</p>
        <p>Irreversible injury to cells as a result of encounters with noxious stimuli invariably leads to cell death. Such noxious stimuli include infectious agents (bacteria, viruses, fungi, parasites), oxygen deprivation or hypoxia, and extreme environmental conditions such as heat, radiation, or exposure to ultraviolet irradiation. The resulting death is known as necrosis, a term that is usually distinguished from the other major consequence of irreversible injury, known as cell death by apoptosis. Apoptosis is a programmed or organized cell death which could be physiological or pathological. Additional information regarding this form of cell death is outside of the scope of this chapter. Necrosis as a form of cell death is almost always associated with a pathological process.</p>
        <p>When cells die by necrosis, they exhibit two major types of microscopes or macroscopic appearance. The first is liquefactive&#x000a0;necrosis, also known as colliquative necrosis, is characterized by partial or complete dissolution of dead tissue and transformation into a liquid, viscous mass. The loss of tissue and cellular profile occurs within hours in liquefactive necrosis. In contrast to liquefactive necrosis, coagulative necrosis, the other major pattern, is characterized by the maintenance of normal architecture of necrotic tissue&#x000a0;for several days after cell death.</p>
        <p>Liquefaction derives from the slimy,&#x000a0;liquid-like nature of tissues undergoing liquefactive necrosis. This morphological appearance is attributable in part to the activities of hydrolytic enzymes which causes dissolution of cellular organelles in a cell undergoing necrosis. The enzymes responsible for liquefaction are derived from either bacterial hydrolytic enzymes or lysosomal hydrolytic enzymes.<xref ref-type="bibr" rid="article-24339.r1">[1]</xref><xref ref-type="bibr" rid="article-24339.r2">[2]</xref><xref ref-type="bibr" rid="article-24339.r3">[3]</xref></p>
        <p>
<bold>Other types of Necrosis</bold>
</p>
        <p>In addition to liquefactive and coagulative necrosis, the other morphological patterns associated with cell death by necrosis are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Caseous Necrosis</p>
          </list-item>
          <list-item>
            <p>Fat Necrosis</p>
          </list-item>
          <list-item>
            <p>Gangrenous Necrosis</p>
          </list-item>
          <list-item>
            <p>Fibrinoid necrosis</p>
          </list-item>
        </list>
        <p>The other types of necrosis listed above do not represent distinct pathological entities. Rather, they are descriptive terms that are widely used to describe necrosis occurring in specific clinical scenarios or organ damage.</p>
        <p>
<bold>Coagulative</bold>
</p>
        <p>This is the default pattern of necrosis associated with ischemia or hypoxia in every organ in the body except the brain.<xref ref-type="bibr" rid="article-24339.r4">[4]</xref><xref ref-type="bibr" rid="article-24339.r5">[5]</xref><bold/></p>
        <list list-type="bullet">
          <list-item>
            <p>Gross Appearance: tissue is firm and architecture is maintained for days after cell death.</p>
          </list-item>
          <list-item>
            <p>Microscopic: Preserved cell outlines without nuclei.</p>
          </list-item>
        </list>
        <p>
<bold>Liquefactive</bold>
</p>
        <p>The pattern of necrosis seen with infections. Also, the pattern is seen following ischemic injury in the brain. While the reason for liquefactive necrosis following ischemic injury in the brain is poorly understood, the release of digestive enzymes and constituents of neutrophils is the reason for liquefaction in infections.<xref ref-type="bibr" rid="article-24339.r6">[6]</xref><xref ref-type="bibr" rid="article-24339.r7">[7]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Gross Appearance: The tissue is in a&#x000a0; liquid form and sometimes creamy yellow because of pus formation.</p>
          </list-item>
          <list-item>
            <p>Microscopic: Inflammatory cells with numerous neutrophils.</p>
          </list-item>
        </list>
        <p>
<bold>Caseous</bold>
</p>
        <p>A unique type of cell death seen with tuberculosis.</p>
        <list list-type="bullet">
          <list-item>
            <p>Gross Appearance: White, soft, cheesy-looking (caseating) material</p>
          </list-item>
          <list-item>
            <p>Microscopic: A uniformly eosinophilic center (necrosis) surrounded by a collar of lymphocytes and activated macrophages (giant cells, epithelioid cells). The entire structure formed in response to tuberculosis is known as a granuloma.</p>
          </list-item>
        </list>
        <p>
<bold>Fat Necrosis</bold>
</p>
        <p>Fat necrosis occurs from acute inflammation affecting tissues with numerous adipocytes such as pancreas and breast tissue. Damaged cells release digestive enzymes which break down lipids to generate free fatty acids.</p>
        <list list-type="bullet">
          <list-item>
            <p>Gross Appearance: Whitish deposits as a result of the formation of calcium soaps.</p>
          </list-item>
          <list-item>
            <p>Microscopic: Anucleated adipocytes with deposits of calcium (Seen on H&#x00026;E as areas of bluish stains).</p>
          </list-item>
        </list>
        <p>
<bold>Fibrinoid Necrosis</bold>
</p>
        <p>This is a pattern associated with vascular damage (autoimmunity, immune-complex deposition, infections (viruses, spirochetes, rickettsiae)).</p>
        <list list-type="bullet">
          <list-item>
            <p>Gross&#x000a0;Appearance: Usually not grossly discernible.</p>
          </list-item>
          <list-item>
            <p>Microscopic: Deposition of fibrin within blood vessels.</p>
          </list-item>
        </list>
        <p>
<bold>Gangrenous Necrosis</bold>
</p>
        <p>Clinical use, to describe ischemic necrosis of the lower limbs.(sometimes upper limbs or digits).</p>
        <list list-type="bullet">
          <list-item>
            <p>Gross&#x000a0;Appearance: Black skin with varying degree of putrefaction.</p>
          </list-item>
          <list-item>
            <p>Microscopic: Combination of coagulative necrosis, due to ischemia (dry gangrene); and liquefactive necrosis (wet gangrene) if a bacterial infection is superimposed.</p>
          </list-item>
        </list>
        <p>These all represents morphological patterns which are visible grossly and microscopically. Fibrinoid necrosis is usually visible only microscopically. We discuss the characteristic gross and microscopic findings in liquefactive necrosis in subsequent paragraphs.</p>
      </sec>
      <sec id="article-24339.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>Patterns of necrosis (liquefactive or coagulative) are determined by the cause of cell death, organ affected, and duration of cell death.</p>
        <p>Liquefactive necrosis is a pattern of cell death caused by several etiological factors.&#x000a0;</p>
        <p>
<bold>The major causes of liquefactive necrosis are:</bold>
</p>
        <p>
<bold>In all solid organs of the body:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Infectious agents (bacteria, fungi, viruses, parasites<bold>)</bold></p>
          </list-item>
        </list>
        <p>
<bold>In the brain</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Infectious agents</p>
          </list-item>
          <list-item>
            <p>Hypoxia/Ischemia (the occurrence of liquefaction as a pattern of necrosis in response to hypoxic injury in the brain is an exception to observed findings in the rest of the body. Tissues in all other mammalian body systems usually undergo cell death by coagulative necrosis in response to hypoxia. The reason for this difference is poorly understood).</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24339.s3" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>
<bold>Liquefactive Necrosis</bold>
</p>
        <p>Three major factors contribute to liquefactive necrosis:</p>
        <list list-type="order">
          <list-item>
            <p>Enzymatic digestion of cellular debris in dead or dying tissues.</p>
          </list-item>
          <list-item>
            <p>Enzymatic digestion of surrounding tissues.</p>
          </list-item>
          <list-item>
            <p>Denaturation of cellular proteins.</p>
          </list-item>
        </list>
        <p>Because infectious agents are rich in digestive enzymes and likely to elicit an inflammatory response, they can bring about the process of cellular digestion rapidly.&#x000a0;This manifests as liquefactive necrosis. Cellular dissolution and digestion are brought about by several enzymes some from the infecting organism and some from the lysosome of the dying cells.</p>
        <p>Enzymes involved in liquefaction includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Proteases (Collagenases, elastases),</p>
          </list-item>
          <list-item>
            <p>DNases</p>
          </list-item>
          <list-item>
            <p>Lysosomal enzymes</p>
          </list-item>
        </list>
        <p>
<bold>Coagulative Necrosis</bold>
</p>
        <p>A major difference between liquefactive and coagulative necrosis is the fact that in liquefactive necrosis, the enzyme system of the necrotic tissue is intact and can commence the process of cellular digestion almost immediately via autolysis. In addition to self-digestion (autolysis), heterolysis occurs as a result of a release of enzymes and inflammatory cells from the invading organism.</p>
        <p>In coagulative necrosis, cellular digestion is principally dependent on heterolysis since a hypoxic injury would have damaged the enzymes of the cell undergoing ischemic necrosis. This partly explains the late onset of digestion and removal of dead tissues in this type of necrosis.</p>
        <p>
<bold>Caseous Necrosis</bold>
</p>
        <p>This pattern is almost unique to tuberculosis. Certain fungi can also exhibit caseous necrosis. In tuberculosis, the organism is partially resistant to digestion and phagocytosis by tissue macrophages, and this leads to activation of the macrophages to form giant cells and epithelioid cells. This sets off several steps which lead to recruitment of more macrophages and inflammatory cells and production of cytokines and slow degradation of the mycobacteria. Mycolic acid and other lipid constituent of the mycobacteria cell wall confers a characteristic "cheese-like" appearance on the tubercle of tuberculosis hence the descriptive term,"caseous."</p>
        <p>
<bold>Fat Necrosis</bold>
</p>
        <p>The release of lipases and amylases from the pancreatic cells is the major trigger for fat necrosis in the pancreas. This processed is usually triggered by several factors leading to inflammation of the pancreas, otherwise known as pancreatitis. Causes of acute pancreatitis include alcohol, gall bladder stones, poisoning, and insect bites. Since fat necrosis in the pancreas is triggered by an inadvertent release of enzymes, this process is also referred to as enzymatic fat necrosis. Breast tissues can also give rise to fat necrosis. The trigger for this is usually trauma.</p>
        <p>
<bold>Fibrinoid Necrosis</bold>
</p>
        <p>This is a pattern which not grossly discernible but can be seen microscopically. Fibrinoid necrosis is a pattern of cell death characterized by endothelial damage and exudation of plasma proteins (especially fibrin).</p>
        <p>
<bold>Gangrenous Necrosis</bold>
</p>
        <p>See description in the introduction above. Not a true pathological type, rather, it is a clinical term describing coagulative necrosis (dry gangrene) or sometimes liquefactive necrosis (wet gangrene) affecting the extremities.</p>
      </sec>
      <sec id="article-24339.s4" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>Clinical Examples of&#x000a0; Necrosis</bold>
</p>
        <p>
<bold>Infections</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Abscesses (brain, lungs, liver, skin)</p>
          </list-item>
          <list-item>
            <p>Lung infections</p>
          </list-item>
          <list-item>
            <p>Skin Infections</p>
          </list-item>
          <list-item>
            <p>Wet Gangrene</p>
          </list-item>
          <list-item>
            <p>Fournier's gangrene</p>
          </list-item>
          <list-item>
            <p>Brain abscess</p>
          </list-item>
        </list>
        <p>
<bold>Hypoxic Injury</bold>
</p>
        <p>Cerebrovascular accident (Stroke) (liquefactive necrosis)</p>
        <p>Acute Tubular Necrosis (Kidneys) (coagulative necrosis)</p>
        <p>Acute Myocardial infarction (coagulative necrosis)</p>
      </sec>
      <sec id="article-24339.s5" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Appropriate history and physical examination findings would guide diagnosis and management including which evaluation studies to order.</p>
        <p>Liquefactive necrosis closely mirrors acute inflammation and response to an infectious process. The only exemption is in the brain where liquefaction may occur in response to ischemia.</p>
        <p>Evaluation and management are geared toward effective clinical management which could be medical with either antibiotics or surgical management.</p>
        <p>Hypoxic injury is the cause of coagulative necrosis. Re-establishment of blood flow or oxygen supply is reperfusion. This is important for management. Hence, for this pattern of tissue damage,&#x000a0;studies&#x000a0;such as Doppler ultrasound&#x000a0;are&#x000a0;useful&#x000a0;to determine blood flow.</p>
        <p>
<bold>Useful evaluation includes:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Physical examination, including monitoring vital signs</p>
          </list-item>
          <list-item>
            <p>Laboratory investigations such (complete blood count, blood culture, urine culture, urinalysis)</p>
          </list-item>
          <list-item>
            <p>Imaging studies such as x-Rays</p>
          </list-item>
          <list-item>
            <p>Venous Doppler Scan</p>
          </list-item>
          <list-item>
            <p>CT</p>
          </list-item>
          <list-item>
            <p>Blood electrolytes</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24339.s6" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Management of Infectious Processes</bold>
</p>
        <p>Antibiotics are the mainstay of managing infectious processes.<xref ref-type="bibr" rid="article-24339.r8">[8]</xref><xref ref-type="bibr" rid="article-24339.r9">[9]</xref><xref ref-type="bibr" rid="article-24339.r10">[10]</xref></p>
        <p>The choice of antibiotic would be guided by clinical findings and antibiotic susceptibility.</p>
        <p>Surgical management is also often indicated and includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Drainage of abscesses</p>
          </list-item>
          <list-item>
            <p>Wound debridement</p>
          </list-item>
          <list-item>
            <p>Amputation</p>
          </list-item>
        </list>
        <p><bold>Management of Ischemic Processes/Stroke</bold> &#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Myocardial infarction is the prototype example of coagulative necrosis which requires urgent management. Early removal of the obstructive lesions in the coronary arteries is a very important step in the management of myocardial infarction.&#x000a0;This is usually achieved medically or by an invasive procedure.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Stroke management is a multi-disciplinary, multi-specialist effort which should take into consideration several factors including, the extent of residual damage, risk of reoccurrence and the rehabilitative needs of the patient.</p>
          </list-item>
        </list>
        <p>
<bold>Management of Caseous Necrosis</bold>
</p>
        <p>This requires standard management for tuberculosis, including the use of combination antibiotics and close laboratory and clinical monitoring.</p>
        <p>
<bold>Management of Gangrenous Necrosis</bold>
</p>
        <p>This is a serious medical and surgical situation which requires antibiotics and sometimes necessitates&#x000a0;the removal of dead tissues (debridement). In severe, life-threatening cases, an amputation may be required.</p>
      </sec>
      <sec id="article-24339.s7" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Complex regional pain syndrome</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Inflammatory synovitis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Osteoarthritis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Osteomyelitis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Soft tissue trauma (e.g., Labral tear)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24339.s8" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>There are several types of necrotic processes that occur following injury or an infection. The final diagnosis of the type of necrosis is made by the pathologist. Sometimes patients may need to be referred to the surgeon or radiologist for aspiration or debridement of the necrotic tissues. Often radical debridement is required in cases of fournier&#x000a0;gangrene and the patient and family should be notified about the possibility of a stoma. If time permits, a stoma nurse should visit patients who are about to undergo an abdominal procedure for gangrene or necrosis.</p>
      </sec>
      <sec id="article-24339.s9">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24339&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24339">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24339/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24339">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-24339.s10">
        <title>References</title>
        <ref id="article-24339.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krishna</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Patterns of necrosis in liver disease.</article-title>
            <source>Clin Liver Dis (Hoboken)</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>53</fpage>
            <page-range>53-56</page-range>
            <pub-id pub-id-type="pmid">30992760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24339.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petek</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hannouche</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Suva</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment.</article-title>
            <source>EFORT Open Rev</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>85</fpage>
            <page-range>85-97</page-range>
            <pub-id pub-id-type="pmid">30993010</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24339.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ye</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Shu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Qin</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Renal histopathology of prolonged acute kidney injury in HELLP syndrome: a case series and literature review.</article-title>
            <source>Int Urol Nephrol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>51</volume>
            <issue>6</issue>
            <fpage>987</fpage>
            <page-range>987-994</page-range>
            <pub-id pub-id-type="pmid">30989562</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24339.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tonnus</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Paliege</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Belavgeni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>von M&#x000e4;ssenhausen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bornstein</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Hugo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>JU</given-names>
              </name>
              <name>
                <surname>Linkermann</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The pathological features of regulated necrosis.</article-title>
            <source>J Pathol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>247</volume>
            <issue>5</issue>
            <fpage>697</fpage>
            <page-range>697-707</page-range>
            <pub-id pub-id-type="pmid">30714148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24339.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lian</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xing</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Coagulative necrotic pituitary adenoma apoplexy: A retrospective study of 21 cases from a large pituitary center in China.</article-title>
            <source>Pituitary</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-28</page-range>
            <pub-id pub-id-type="pmid">30390276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24339.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zeng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Mao</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>MRI evaluation of pulmonary lesions and lung tissue changes induced by tuberculosis.</article-title>
            <source>Int J Infect Dis</source>
            <year>2019</year>
            <month>May</month>
            <volume>82</volume>
            <fpage>138</fpage>
            <page-range>138-146</page-range>
            <pub-id pub-id-type="pmid">30872041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24339.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chung</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Frye</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Zbesko</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Constantopoulos</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hayes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Figueroa</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Becktel</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Antony Day</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Konhilas</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>McKay</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>TV</given-names>
              </name>
              <name>
                <surname>Doyle</surname>
                <given-names>KP</given-names>
              </name>
            </person-group>
            <article-title>Liquefaction of the Brain following Stroke Shares a Similar Molecular and Morphological Profile with Atherosclerosis and Mediates Secondary Neurodegeneration in an Osteopontin-Dependent Mechanism.</article-title>
            <source>eNeuro</source>
            <year>2018</year>
            <season>Sep-Oct</season>
            <volume>5</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">30417081</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24339.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shahid</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Endoscopic management of pancreatic fluid collections.</article-title>
            <source>Transl Gastroenterol Hepatol</source>
            <year>2019</year>
            <volume>4</volume>
            <fpage>15</fpage>
            <pub-id pub-id-type="pmid">30976718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24339.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wong</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Feuerstein</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Poylin</surname>
                <given-names>VY</given-names>
              </name>
            </person-group>
            <article-title>Surgery in the age of biologics.</article-title>
            <source>Gastroenterol Rep (Oxf)</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>77</fpage>
            <page-range>77-90</page-range>
            <pub-id pub-id-type="pmid">30976420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24339.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Arcy</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Cell death: a review of the major forms of apoptosis, necrosis and autophagy.</article-title>
            <source>Cell Biol Int</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>43</volume>
            <issue>6</issue>
            <fpage>582</fpage>
            <page-range>582-592</page-range>
            <pub-id pub-id-type="pmid">30958602</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
